Immune-attractant: Clinical Trials

1 trial of Immune-attractant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Immune-attractant: new trials by email Literature Review of Immune-attractant trials Research Report on Immune-attractant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
Immune-attractant, Durvalumab, Biopsy - Breast Cancer, Estrogen Receptor Positive Tumor
Phase 2CompletedUNICANCER612017-02-152020-09-30

Conditions studied

Breast Neoplasms (1)

Sponsors

UNICANCER (1)

Countries

France (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Fabrice Andre, Prof (1)

NIH funding

2016 (1)